Empire Genomics is a molecular and cytogenetic diagnostics company that offers a comprehensive menu of assay services for use in diagnosing and guiding precise therapeutic treatments for patients. Our services are designed to specifically meet the needs of pathologists, oncologists, and researchers. Our mission is to enable personalized medicine through the development and implementation of genetic assays. We hope that as this testing becomes more accessible and affordable, patients will experience faster and more effective drug development, lower healthcare costs, and better clinical outcomes. Empire Genomics is uniquely positioned to bring this innovative service to the medical community through its highly qualified team, CAP and CLIA certified facilities and key strategic partnerships with leaders in the global research community. We are a resource to make personalized medicine a reality.